<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04455165</url>
  </required_header>
  <id_info>
    <org_study_id>CCVT-RVAoMITAVARegistry</org_study_id>
    <nct_id>NCT04455165</nct_id>
  </id_info>
  <brief_title>Factors Influencing Morbi-mortality in Right Anterior Minithoracotomy Approch for Aortic Valve Replacement</brief_title>
  <acronym>RVAOMITAVA</acronym>
  <official_title>Factors Influencing Morbi-mortality in Right Anterior Minithoracotomy Approch for Aortic Valve Replacement Operated at Dijon University Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier La Chartreuse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier La Chartreuse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since 2009, positive experiences with right anterior minithoracotomy as an approach to aortic
      valve replacement are extensively practiced in our institution. The primary disease process
      for which patients are referred remains aortic stenosis. But more and more, we met older
      patients with both aortic stenosis and other cardiac pathology (coronary artery disease,
      other valvulopathy...). Even if minimally invasive valve surgery has been demonstrated to
      significantly improve postoperative course (reduced blood transfusion, pain, hospital lengths
      of stay) and to enhance postoperative recovery, when compared with a median sternotomy, it is
      however important to have medical data and statistics in order to better understand the
      factors influencing morbi-mortality and thereby to continue this improvement.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 29, 2020</start_date>
  <completion_date type="Actual">June 29, 2020</completion_date>
  <primary_completion_date type="Actual">June 29, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>30 days mortality incidence rates</measure>
    <time_frame>30 days</time_frame>
    <description>Mortality from aortic valve replacement to 30 days post-surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>30 days morbidity incidence rates</measure>
    <time_frame>30 days</time_frame>
    <description>Morbidity from aortic valve replacement to 30 days post-surgery (major adverse cardiac events)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term morbimortality incidence rates</measure>
    <time_frame>10 years</time_frame>
    <description>Morbimortality from aortic valve replacement up to 10 years post-surgery</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Aortic Valve Disease</condition>
  <arm_group>
    <arm_group_label>RVAo MITAVA</arm_group_label>
    <description>Patient operated since 2009 for aortic valve replacement through right anterior minithoracotomy approch in Dijon Burgundy University Hospital</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Aortic valve replacement</intervention_name>
    <description>Aortic valve replacement with or without associated cardiac surgery (coronary bypass, mitral valve surgery,...)</description>
    <arm_group_label>RVAo MITAVA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patient operated for aortic valve replacement with or without associated cardiac
        surgery from 2009 in Dijon University Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; 18 y-o who underwent aortic valve replacement

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Catherine MORGANT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dijon University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiovascular and thoracic surgery Unit - Dijon University Hopital</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 29, 2020</study_first_submitted>
  <study_first_submitted_qc>June 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2020</study_first_posted>
  <last_update_submitted>July 2, 2020</last_update_submitted>
  <last_update_submitted_qc>July 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier La Chartreuse</investigator_affiliation>
    <investigator_full_name>MORGANT Marie-Catherine</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>All patients signed a institutional form prior to the procedure stating that they did not object to the use of their medical data for research purposes. Before inclusion, all patients (or a trusted person) were informed about the study and its objectives. No opposition was expressed.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

